|
Primary
|
Reduction in inappropriate prescribing
|
EHR
|
Composite of (1) discontinuation of high-risk medications or (2) ordering a gradual dose taper
|
End of stages 1 and 2
|
|
Secondary
|
Quantity of prescribing
|
EHR
|
Number of milligram equivalents of high-risk medications prescribed to patients
|
End of stage 2
|
|
Tertiary
|
Quantity of medication dispensed
|
Administrative claims
|
Number of milligram equivalents of high-risk medications filled by patients
|
End of stage 2
|
|
Adverse events
|
Administrative claims
|
Occurrence of clinically significant adverse drug events, such as all-cause hospitalizations, falls, and fractures
|
End of stage 2
|
